Endurant Capital Management LP Praxis Precision Medicines, Inc. Transaction History

Endurant Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.75 - $11.34 $621 - $4,025	-355 Reduced 0.45%	79,097 $194,000
Q1 2022 May 16, 2022	SELL	$10.21 - $20.29 $103,212 - $205,111	-10,109 Reduced 11.29%	79,452 $811,000
Q4 2021 Feb 14, 2022	SELL	$16.76 - $22.99 $1.07 Million - $1.47 Million	-64,038 Reduced 41.69%	89,561 $1.76 Million
Q3 2021 Nov 15, 2021	SELL	$13.15 - $22.56 $604,452 - $1.04 Million	-45,966 Reduced 23.03%	153,599 $2.84 Million
Q2 2021 Aug 16, 2021	BUY	$18.28 - $33.05 $3.65 Million - $6.6 Million	199,565 New	199,565 $3.65 Million

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.